Novel antipsychotic use in schizophrenia.
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001569:Benzodiazepines; D003987:Dibenzothiazepines / Q000627:therapeutic use; D003988:Dibenzothiepins / Q000627:therapeutic use; D004334:Drug Administration Schedule; D006801:Humans; D000077152:Olanzapine; D010879:Piperazines / Q000627:therapeutic use; D010890:Pirenzepine / Q000031:analogs & derivatives / Q000627:therapeutic use; D010818:Practice Patterns, Physicians'; D000069348:Quetiapine Fumarate; D018967:Risperidone / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy*; D013844:Thiazoles / Q000627:therapeutic use; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D003988:Dibenzothiepins; D010879:Piperazines; D013844:Thiazoles; D001569:Benzodiazepines; D000069348:Quetiapine Fumarate; D010890:Pirenzepine; C092292:ziprasidone; D018967:Risperidone; D000077152:Olanzapine; C022172:zotepine